Bardia Lajevardi, Armin Talle, Mehrtash Hashemzadeh, Mohammad Reza Movahed
{"title":"体重对冠状动脉旁路移植术患者死亡率的影响呈l型。","authors":"Bardia Lajevardi, Armin Talle, Mehrtash Hashemzadeh, Mohammad Reza Movahed","doi":"10.1080/14796678.2024.2440247","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The role of body composition as a risk factor for adverse outcomesduring coronary artery bypass surgery (CABG) has been controversial. The goal of this study was to evaluate the effect of body weight on mortality in patients undergoing CABG.</p><p><strong>Method: </strong>Using a large NIS database and ICD-10 coding for different bodyweight categories, we evaluated the effect of cachexia, overweight, obesity, and morbid obesity on in-hospital mortality after CABG. We evaluated the available database containing ICD10 coding from 2016- 2020.</p><p><strong>Results: </strong>We found that cachexia was the strongest independent predictor of in-hospital mortality whereas obesity had a protective effect. Over the 4-year sample size, patients with cachexia had nearly a 4-fold increase in mortality compared to patients with normal weight despite adjusting for age and comorbidities (4.06 CI 2.7-6.0, <i>p</i> < 0.001). Patients with overweight and Obesity had the lowest mortality (OR = 0.44 CI 0.29-0.66, OR = 0.58 CI 0.52-0.63, p, 001). However, the mortality benefit disappeared in patients with morbid obesity (OR 0.9, CI 0.84-1.03, <i>p</i> = 0.15) with a trend of higher mortality in patients with morbid obesity after multivariate adjustment.</p><p><strong>Conclusion: </strong>Cachexia is a powerful predictor for in-hospital mortality in patients undergoing CABG. Overweight and obesity have protective effect which disappears with morbid obesity.</p>","PeriodicalId":12589,"journal":{"name":"Future cardiology","volume":" ","pages":"9-14"},"PeriodicalIF":1.6000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11812328/pdf/","citationCount":"0","resultStr":"{\"title\":\"Bodyweight affects mortality in an L-shape pattern in patients undergoing coronary bypass grafting.\",\"authors\":\"Bardia Lajevardi, Armin Talle, Mehrtash Hashemzadeh, Mohammad Reza Movahed\",\"doi\":\"10.1080/14796678.2024.2440247\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>The role of body composition as a risk factor for adverse outcomesduring coronary artery bypass surgery (CABG) has been controversial. The goal of this study was to evaluate the effect of body weight on mortality in patients undergoing CABG.</p><p><strong>Method: </strong>Using a large NIS database and ICD-10 coding for different bodyweight categories, we evaluated the effect of cachexia, overweight, obesity, and morbid obesity on in-hospital mortality after CABG. We evaluated the available database containing ICD10 coding from 2016- 2020.</p><p><strong>Results: </strong>We found that cachexia was the strongest independent predictor of in-hospital mortality whereas obesity had a protective effect. Over the 4-year sample size, patients with cachexia had nearly a 4-fold increase in mortality compared to patients with normal weight despite adjusting for age and comorbidities (4.06 CI 2.7-6.0, <i>p</i> < 0.001). Patients with overweight and Obesity had the lowest mortality (OR = 0.44 CI 0.29-0.66, OR = 0.58 CI 0.52-0.63, p, 001). However, the mortality benefit disappeared in patients with morbid obesity (OR 0.9, CI 0.84-1.03, <i>p</i> = 0.15) with a trend of higher mortality in patients with morbid obesity after multivariate adjustment.</p><p><strong>Conclusion: </strong>Cachexia is a powerful predictor for in-hospital mortality in patients undergoing CABG. Overweight and obesity have protective effect which disappears with morbid obesity.</p>\",\"PeriodicalId\":12589,\"journal\":{\"name\":\"Future cardiology\",\"volume\":\" \",\"pages\":\"9-14\"},\"PeriodicalIF\":1.6000,\"publicationDate\":\"2025-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11812328/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Future cardiology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1080/14796678.2024.2440247\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/1/5 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q3\",\"JCRName\":\"CARDIAC & CARDIOVASCULAR SYSTEMS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Future cardiology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1080/14796678.2024.2440247","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/5 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0
摘要
背景:体成分作为冠状动脉搭桥手术(CABG)不良结果的危险因素的作用一直存在争议。本研究的目的是评估体重对冠脉搭桥患者死亡率的影响。方法:利用大型NIS数据库和不同体重类别的ICD-10编码,我们评估了病毒质、超重、肥胖和病态肥胖对冠状动脉绕道术后住院死亡率的影响。我们评估了包含2016- 2020年ICD10编码的可用数据库。结果:我们发现恶病质是院内死亡率最强的独立预测因子,而肥胖具有保护作用。在4年的样本量中,尽管调整了年龄和合并症,但恶病质患者的死亡率比正常体重患者增加了近4倍(4.06 CI 2.7-6.0, p p = 0.15),并且在多因素调整后,病态肥胖患者的死亡率有更高的趋势。结论:恶病质是冠脉搭桥患者住院死亡率的重要预测因子。超重和肥胖具有保护作用,但随着病态肥胖而消失。
Bodyweight affects mortality in an L-shape pattern in patients undergoing coronary bypass grafting.
Background: The role of body composition as a risk factor for adverse outcomesduring coronary artery bypass surgery (CABG) has been controversial. The goal of this study was to evaluate the effect of body weight on mortality in patients undergoing CABG.
Method: Using a large NIS database and ICD-10 coding for different bodyweight categories, we evaluated the effect of cachexia, overweight, obesity, and morbid obesity on in-hospital mortality after CABG. We evaluated the available database containing ICD10 coding from 2016- 2020.
Results: We found that cachexia was the strongest independent predictor of in-hospital mortality whereas obesity had a protective effect. Over the 4-year sample size, patients with cachexia had nearly a 4-fold increase in mortality compared to patients with normal weight despite adjusting for age and comorbidities (4.06 CI 2.7-6.0, p < 0.001). Patients with overweight and Obesity had the lowest mortality (OR = 0.44 CI 0.29-0.66, OR = 0.58 CI 0.52-0.63, p, 001). However, the mortality benefit disappeared in patients with morbid obesity (OR 0.9, CI 0.84-1.03, p = 0.15) with a trend of higher mortality in patients with morbid obesity after multivariate adjustment.
Conclusion: Cachexia is a powerful predictor for in-hospital mortality in patients undergoing CABG. Overweight and obesity have protective effect which disappears with morbid obesity.
期刊介绍:
Research advances have contributed to improved outcomes across all specialties, but the rate of advancement in cardiology has been exceptional. Concurrently, the population of patients with cardiac conditions continues to grow and greater public awareness has increased patients" expectations of new drugs and devices. Future Cardiology (ISSN 1479-6678) reflects this new era of cardiology and highlights the new molecular approach to advancing cardiovascular therapy. Coverage will also reflect the major technological advances in bioengineering in cardiology in terms of advanced and robust devices, miniaturization, imaging, system modeling and information management issues.